PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+5.34%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.47B
AUM Growth
+$2.47B
(-1.1%)
Cap. Flow
-$76.4M
Cap. Flow
% of AUM
-3.09%
Top 10 Holdings %
Top 10 Hldgs %
69.94%
Holding
36
New
–
Increased
10
Reduced
3
Closed
–
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$7.25M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$4.38M |
| 3 |
CELG
Celgene Corp
CELG
|
$3.08M |
| 4 |
Insmed
INSM
|
$2.44M |
| 5 |
Amicus Therapeutics
FOLD
|
$2.39M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$81.6M |
| 2 |
Align Technology
ALGN
|
$14.4M |
| 3 |
ACGN
Aceragen, Inc. Common Stock
ACGN
|
$4.8M |
Sector Composition
| 1 | Healthcare | 91.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $319M | 12.89% | 708,917 -181,392 | -20% | -$81.6M |
|
2
BioMarin Pharmaceuticals
BMRN
$11.2B
| $247M | 9.99% | 2,549,431 | – | – |
|
3
United Therapeutics
UTHR
$13.8B
| $208M | 8.4% | 1,625,234 | – | – |
|
4
STAAR Surgical
STAA
$1.36B
| $169M | 6.83% | 3,521,565 | – | – |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $167M | 6.74% | 1,200,201 +13,774 | +1% | +$1.91M |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $153M | 6.2% | 5,221,026 +247,019 | +5% | +$7.25M |
|
|
7
Insmed
INSM
$28.8B
| $149M | 6.01% | 7,357,283 +120,700 | +2% | +$2.44M |
|
|
SAGE
8
DELISTED
Sage Therapeutics
SAGE
| $119M | 4.8% | 840,372 +7,836 | +0.9% | +$1.11M |
|
|
IMMU
9
DELISTED
Immunomedics Inc
IMMU
| $104M | 4.22% | 5,013,764 +210,400 | +4% | +$4.38M |
|
10
Vanda Pharmaceuticals
VNDA
$279M
| $95.4M | 3.85% | 4,155,670 | – | – |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $80M | 3.23% | 2,757,587 | – | – |
|
12
Karyopharm Therapeutics
KPTI
$61.7M
| $79.4M | 3.21% | 4,663,324 | – | – |
|
|
13
Amicus Therapeutics
FOLD
$2.34B
| $77M | 3.11% | 6,366,147 +197,800 | +3% | +$2.39M |
|
|
EPZM
14
DELISTED
Epizyme, Inc
EPZM
| $73.2M | 2.96% | 6,906,158 | – | – |
|
|
AMAG
15
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $67.6M | 2.73% | 3,380,506 +39,700 | +1% | +$794K |
|
|
16
Align Technology
ALGN
$10.3B
| $57.8M | 2.34% | 147,807 -36,800 | -20% | -$14.4M |
|
|
MNTA
17
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $48.2M | 1.95% | 1,833,532 | – | – |
|
|
CELG
18
DELISTED
Celgene Corp
CELG
| $38.4M | 1.55% | 429,267 +34,427 | +9% | +$3.08M |
|
|
AIMT
19
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $37.7M | 1.52% | 1,381,759 | – | – |
|
20
Acadia Pharmaceuticals
ACAD
$4.38B
| $35M | 1.41% | 1,684,180 +33,400 | +2% | +$693K |
|
|
SHPG
21
DELISTED
Shire pic
SHPG
| $34.9M | 1.41% | 192,738 +1,538 | +0.8% | +$279K |
|
|
ALDR
22
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $30.9M | 1.25% | 1,853,101 | – | – |
|
23
Exact Sciences
EXAS
$8.98B
| $24.7M | 1% | 313,320 | – | – |
|
24
Prothena Corp
PRTA
$441M
| $14.4M | 0.58% | 1,103,325 | – | – |
|
25
Gilead Sciences
GILD
$140B
| $13.6M | 0.55% | 175,900 | – | – |
|